RESEARCH TRIANGLE PARK, NC--(Marketwire - April 30, 2008) - A new study released by Cutting
Edge Information reveals that a large majority of pharmaceutical companies
now have dedicated groups to receive, evaluate and manage investigator
initiated trials. The study, "Investigator-Initiated Trials: Building
Superior IIT Capabilities," finds that 75% of companies fund dedicated IIT
management groups.
Cutting Edge Information reveals that the prevalence of IIT groups has
increased 25% since previous research performed in the IIT arena. Of the
companies that do not have a dedicated group, only 6% are US-based
companies. According to survey data, the increase in dedicated groups has
coincided with a significant increase in the perceived value of IIT groups
and their impact on corporate success.
"In an effort to run leaner organizations, drug companies are seeking ways
to centralize critical functions that may have been distributed among
business units or franchises," says lead author of the report, Eric
Bolesh. "Creating dedicated IIT management is a structural shift that
focuses resources on an important part of ongoing drug development."
By centralizing IIT management, companies are able more fully leverage
their connections to the medical community. Through tools such as global
online IIT proposal submission systems, dedicated IIT functions have made
it easy and efficient for independent physicians, researchers and thought
leaders to come to them with research ideas.
To offer a comprehensive look at the current state of IIT management, the
report provides data benchmarks that will enable companies to improve their
IIT initiatives. Findings center on the following topics:
-- Companies' assessments of IIT performance and areas of improvement
-- Study proposal review and evaluation timelines
-- Budgets and funding
-- IIT program profiles
Surveyed respondents reveal difficulties in selecting viable study
opportunities, tracking studies, overseeing clinical trial management and
making use of study findings. Beyond identifying these obstacles, however,
companies provide creative solutions. Based on data and these insights,
the report authors recommend strategies to optimize IIT performance.
Download a free summary of "Investigator-Initiated Trials: Building
Superior IIT Capabilities" or purchase the report at:
http://www.cuttingedgeinfo.com/investigatorinitiatedtrials/PH114_Download.asp#body.
Contact Information: CONTACT:
Eric Bolesh
919-433-0209